Ptaszek et al.
JOCArticle
(CH2Cl2) afforded a red-brown solid (41 mg, 74%): 1H NMR δ
-1.55 (br s, 2H), 1.84 (s, 6H), 1.98 (s, 6H), 2.59 (s, 3H), 4.56 (s,
2H), 7.23 (s, 2H), 7.29-7.34 (m, 2H), 7.48 (t, J = 7.8 Hz, 2H),
7.55 (t, J=7.8 Hz, 2H), 7.85 (d, J=7.7 Hz, 2H), 7.98 (d, J=7.7
Hz, 2H), 8.02 (s, 1H), 8.39 (d, J=4.4 Hz, 1H), 8.64 (s, 1H), 8.75
(s, 1H), 8.77 (s, 1H), 8.85 (d, J=4.4 Hz, 1H), 9.20 (s, 1H), 10.55
(s, 1H); ESI-MS obsd 775.2393, calcd 775.2391 [(MþH)þ, M=
C45H39BrN6O2]; λabs (CH2Cl2) 412, 518, 549, 614, 668 nm.
132-N-Benzyl-17,18-dihydro-10-mesityl-18,18-dimethylporphy-
rin-13,15-dicarboximide (FbC-M10I-Bn). Samples of FbC-M10-
(CmBn)13Br15 (15.2 mg, 0.0226 mmol) and Pd(PPh3)4 (26.1 mg,
0.0226 mmol) were reacted in toluene/DMF [1.5 mL, (1:1)] at
80 °C for 2 h under an atmosphere of CO as described in the
General Procedure. The flow of CO was then stopped, and the
reaction mixture was kept at 80 °C for 1 h. The reaction mixture
was filtered through Celite (CH2Cl2) and concentrated. Column
chromatography (silica, CH2Cl2) provided the title compound
(first fraction, purple) and debrominated starting material
(second fraction, 6.5 mg). Data for the title compound: purple
solid (7 mg, 50%): 1H NMR δ 0.08 (br s, 1H), 0.43 (br s, 1H),
1.86 (s, 6H), 1.95 (s, 6H), 2.58 (s, 3H), 4.82 (s, 2H), 5.67 (s, 2H),
7.20 (s, 2H), 7.24-7.28 (m, 1H, partially overlapped with
residual CHCl3), 7.34-7.39 (m, 2H), 7.74-7.76 (m, 2H), 8.26
(d, J = 4.4 Hz, 1H), 8.53 (s, 1H), 8.53 (d, partially overlapped
with singlet), 8.66 (d, J=4.8 Hz, 1H), 8.94 (d, J=4.8 Hz, 1H),
8.99 (s, 1H), 9.32 (s, 1H); 13C NMR (75 MHz) δ 21.4, 21.6, 31.5,
46.4, 51.4, 54.0, 93.7, 96.1, 110.2, 119.7, 123.9, 125.9, 127.1,
128.3, 128.5, 128.7, 128.8, 131.1, 133.2, 133.7, 136.6, 137.1,
138.4, 138.6, 138.7, 140.3, 144.5, 147.3, 153.2, 154.2, 164.5,
171.9, 180.9; LD-MS obsd 618.0; ESI-MS obsd 618.2866, calcd
618.2864 [(M þ H)þ, M = C40H35N5O2]; λabs 363, 420, 553,
686 nm.
Hz, 1H), 8.55 (s, 1H, overlapped with doublet), 8.68 (d, J=4.8 Hz,
1H), 8.97 (d, J = 4.8 Hz, 1H), 9.03 (s, 1H), 9.34 (s, 1H); LD-MS
obsd 603.8; ESI-MS obsd 604.2712, calcd 604.2707 [(MþH)þ, M=
C39H33N5O2]; λabs 364, 419, 551, 685 nm.
131-N-Phenylimino-17,18-dihydro-10-mesityl-18,18-dimethyl-
porphyrin-13,15-dicarboxisoimide (FbC-M10Iso-Ph). Samples of
FbC-M10(CmPh)13Br15 (23.5 mg, 0.0358 mmol), Pd(PPh3)4
(41.3 mg, 0.0358 mg), and Cs2CO3 (35.0 mg, 0.107 mmol) were
reacted in toluene (1.4 mL) at 80 °C for 2 h under an atmosphere
of CO as described in the General Procedure. The resulting
mixture was diluted with CH2Cl2, filtered through Celite, and
concentrated. Column chromatography [silica, hexanes/CH2-
1
Cl2 (1:3)] afforded a purple solid (12.8 mg, 59%): H NMR δ
-0.41 (br s, 1H), 0.07 (br s, 1H); 1.90 (s, 6H), 2.00 (s, 6H), 2.59 (s,
3H), 4.87 (s, 2H), 7.24 (s, 2H), 7.23-7.24 (m, 1H, overlapped
with singlet), 7.47-7.51 (m, 2H), 7.53-7.56 (m, 2H), 8.33 (d, J=
4.4 Hz, 1H), 8.65 (d, J=4.4 Hz, 1H), 8.68 (s, 1H), 8.76 (d, J=
4.7 Hz, 1H), 9.05 (d, J=4.7 Hz, 1H), 9.13 (s, 1H), 9.49 (s, 1H);
13C NMR δ 21.1, 21.4, 31.2, 46.2, 53.7, 93.5, 95.9, 109.9, 119.3,
123.7, 124.1, 124.8, 126.0, 128.1, 128.6, 128.9, 131.1, 133.0,
133.2, 133.6, 136.3, 137.2, 138.3, 138.5, 144.7, 145.4, 145.7,
153.0, 154.3, 164.0, 172.0, 181.2 (signal of one carbon is not
visible); ESI-MS obsd 604.2711, calcd 604.2707 [(MþH)þ, M=
C39H33N5O2]; λabs 367, 418, 512, 550, 634, 687 nm.
132-N-Benzyl-3-(N-benzylcarbamoyl)-17,18-dihydro-10-mesityl-
18,18-dimethylporphyrin-13,15-dicarboximide (FbC-(CmBn)3M10I-
Bn). Samples of FbC-M10(CmBn)3,13Br15 (20.5 mg, 0.0255 mmol),
Pd(PPh3)4 (29.5 mg, 0.0255 mmol), and Cs2CO3 (25 mg, 0.077
mmol) were reacted in toluene (4.0 mL) at 80 °C for 20 h under an
atmosphere of CO as described in the General Procedure. The
reaction mixture was filtered through Celite (ethyl acetate) and
concentrated. Column chromatography (silica, CH2Cl2) gave two
fractions; the first fraction afforded the title compound as a purple
solid (6.1 mg, 32%); the second fraction afforded the chlorin-
isoimide FbC-(CmBn)3M10Iso-Bn as a purple solid (5.0 mg, 26%).
Data for FbC-(CmBn)3M10I-Bn:1HNMRδ0.11 (br s, 1H), 0.29 (br
s, 1H), 1.85 (s, 6H), 1.92 (s, 6H), 2.58 (s, 3H), 4.82 (s, 2H), 5.01 (d,
J = 5.8 Hz, 2H), 5.66 (s, 2H), 7.21 (s, 2H), 7.32-7.44 (m, 3H),
7.43-7.52 (m, 2H), 7.55-7.64 (m, 2H), 7.66-7.79 (m, 3H), 8.25 (d,
J=4.4 Hz, 1H), 8.53 (s, 1H), 8.65 (d, J=4.7 Hz, 1H), 8.85 (s, 1H),
9.05 (s, 1H), 10.34 (s, 1H); ESI-MS obsd 751.3392, calcd 751.3391
[(MþH)þ, M=C48H42N6O3]; λabs 378, 424, 564, 708 nm. Data for
FbC-(CmBn)3M10Iso-Bn: 1H NMR δ -0.42 (br s, 1H), -0.14 (br s,
1H), 1.83 (s, 6H), 1.97 (s, 6H), 2.57 (s, 3H), 4.90 (s, 2H), 5.03 (d, J=
5.6 Hz, 2H), 5.23 (s, 2H), 7.20 (s, 2H), 7.43 (m, 5 H), 7.57-7.67 (m,
3H), 7.67-7.80 (m, 2H), 8.26 (d, J=4.4 Hz, 1H), 8.66 (s, 1H), 8.74
(d, J=4.4 Hz, 1H), 8.93 (s, 1H), 9.06 (s, 1H), 10.52 (s, 1H); ESI-MS
obsd 751.3393, calcd 751.3391 [(M þH)þ, M=C48H42N6O3]; λabs
418, 555, 699 nm.
131-N-Benzylimino-17,18-dihydro-10-mesityl-18,18-dimethyl-
porphyrin-13,15-dicarboxisoimide (FbC-M10Iso-Bn). Samples of
FbC-M10(CmBn)13Br15 (24.3 mg, 0.0362 mmol), Pd(PPh3)4
(41.8 mg, 0.0362 mmol), and Cs2CO3 (35.7 mg, 0.109 mmol)
were reacted in toluene (1.5 mL) at 80 °C for 2 h under an
atmosphere of CO as described in the General Procedure. The
resulting mixture was diluted with CH2Cl2, filtered through
Celite, and concentrated. Column chromatography (silica,
CH2Cl2) afforded a trace of FbC-M10I-Bn (first fraction, purple)
and the title compound (second fraction, purple), which upon
concentration afforded a purple solid (12.2 mg, 55%): 1H NMR
δ - 0.55 (br s, 1H), - 0.12 (br s, 1H), 1.84 (s, 6H), 2.02 (s, 6H),
2.57 (s, 3H), 4.92 (s, 2H), 5.24 (s, 2H), 7.20 (s, 2H), 7.30-7.33 (m,
1H), 7.40-7.45 (m, 2H), 7.64-7.67 (m, 2H), 8.30 (d, J=4.4 Hz,
1H), 8.65 (d, J=4.4 Hz, 1H), 8.70 (s, 1H), 8.77 (d, J=4.8 Hz,
1H), 9.04 (s, 1H), 9.06 (d, J = 4.8 Hz, 1H), 9.51 (s, 1H); 13C
NMR (75 MHz) δ 21.1, 21.4, 31.3, 46.2, 51.2, 53.8, 53.5, 95.8,
110.0, 119.5, 123.7, 125.7, 126.9, 128.0, 128.3, 128.5, 128.6,
130.9, 132.9, 130.0, 133.5, 136.4, 136.9, 138.2, 138.35, 138.44,
140.1, 144.3, 147.0, 152.9, 153.9, 164.2, 171.7, 180.7; LD-MS
obsd 617.8, 526.7 (M - Bn)þ; ESI-MS obsd 618.2857, calcd
618.2864 [(MþH)þ, M=C40H35N5O2]; λabs 363, 414, 507, 544,
625, 679 nm.
132-N-Phenyl-3-(N-phenylcarbamoyl)-17,18-dihydro-10-mesityl-
18,18-dimethylporphyrin-13,15-dicarboximide (FbC-(CmPh)3M10I-
Ph). Samples of FbC-M10(CmPh)3,13Br15 (10.0 mg, 0.0129 mmol),
Pd(PPh3)4 (14.8 mg, 0.0129 mmol), and Cs2CO3 (12.6 mg, 0.0387
mmol) were reacted in toluene (2.0 mL) at 80 °C for 20 h under
an atmosphere of CO as described in the General Procedure.
The reaction mixture was filtered through Celite (ethyl acetate)
and concentrated. Column chromatography on a short silica
column (CH2Cl2) afforded a purple-green solid (6.7 mg, 72%):
1H NMR δ 0.19 (br s, 1H), 0.42 (br s, 1H), 1.87 (s, 6H), 1.92
(s, 6H), 2.58 (s, 3H), 4.80 (s, 2H), 7.22 (s, 2H), 7.53 (m, 6H), 7.64 (d,
J = 7.4 Hz, 2H), 7.93 (d, J = 7.7 Hz, 2H), 8.25 (d, J = 4.4 Hz,
1H), 8.55 (s, 1H), 8.60 (s, 1H), 8.66 (d, J = 4.7 Hz, 1H), 8.98 (s,
1H), 9.11 (s, 1H), 10.35 (s, 1H); ESI-MS obsd 723.3076, calcd
723.3078 [(M þ H)þ, M = C46H38N6O3]; λabs (CH2Cl2) 422, 565,
660, 710 nm.
132-N-Phenyl-17,18-dihydro-10-mesityl-18,18-dimethylpor-
phyrin-13,15-dicarboximide (FbC-M10I-Ph). Samples of FbC-
M10(CmPh)13Br15 (7.0 mg, 0.011 mmol), Pd(PPh3)4 (2.5 mg,
0.0022 mmol), and Cs2CO3 (10.7 mg, 0.033 mmol) were reacted
in toluene (1 mL) at 80 °C for 14 h under an atmosphere of CO as
described in the General Procedure. The reaction mixture was
diluted with CH2Cl2, filtered through Celite, and chromato-
graphed [silica, hexanes/CH2Cl2, (1:1 to 3:1)] to afford a trace of
debrominated starting material (first fraction), unreacted starting
material (second fraction), and the title compound (third fraction,
3 mg, 45%): 1HNMRδ0.15 (br s, 1H), 0.58 (br s, 1H), 1.88 (s, 6H),
1.93 (s, 6H), 2.58 (s, 3H), 4.79 (s, 2H), 7.21 (s, 2H), 7.56-7.58 (m,
3H), 7.63-7.68 (m, 2H), 8.26 (d, J=4.4 Hz, 1H), 8.55 (d, J=4.4
132-N-Benzyl-3-methoxycarbonyl-17,18-dihydro-10-mesityl-18,18-
dimethylporphyrin-13,15-dicarboximide (FbC-Es3M10I-Bn). Samples
of FbC-M10Es3,13Br15 (35.5 mg, 0.0543 mmol), Pd(PPh3)4 (63.0 mg,
1672 J. Org. Chem. Vol. 75, No. 5, 2010